Updating results

152 results for kidney cancer Sort: Relevance | Date

New deal will give people with kidney cancer another treatment option

People with advanced kidney cancer are set to benefit from a new treatment, after NICE has said lenvatinib should be available on the NHS.

News Published December 2017

Renal cancer

Everything NICE has said on renal (kidney) cancer in an interactive flowchart

NICE Pathway Published December 2013 Last updated November 2017

Kidney conditions

Everything NICE has said on kidney conditions in an interactive flowchart

NICE Pathway Published May 2015 Last updated June 2017

Acute kidney injury: prevention, detection and management (CG169)

Evidence-based recommendations on the prevention, detection and management of acute kidney injury (AKI)

Clinical guideline Published August 2013

Urogenital conditions

Everything NICE has said on urogenital conditions in an interactive flowchart

NICE Pathway Published June 2015 Last updated December 2017

Laparoscopic nephrectomy (including nephroureterectomy) (IPG136)

Evidence-based recommendations on laparoscopic nephrectomy (including nephroureterectomy; keyhole surgery to remove a kidney)

Interventional procedures guidance Published August 2005

Urinary incontinence in neurological disease: assessment and management (CG148)

Evidence-based recommendations on assessing and managing urinary incontinence (lower urinary tract dysfunction) in people with a neurological condition

Clinical guideline Published August 2012

Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma (TA169)

Evidence-based recommendations on sunitinib (Sutent) for the first-line treatment of advanced and/or metastatic renal cell carcinoma

Technology appraisal guidance Published March 2009

Laparoscopic cryotherapy for renal cancer (IPG405)

Evidence-based recommendations on laparoscopic cryotherapy (keyhole surgery to destroy cancer cells by freezing) for treating renal (kidney) cancer

Interventional procedures guidance Published August 2011

Percutaneous cryotherapy for renal cancer (IPG402)

Evidence-based recommendations on percutaneous cryotherapy for renal (kidney) cancer

Interventional procedures guidance Published July 2011

Irreversible electroporation for treating renal cancer (IPG443)

Evidence-based recommendations on irreversible electroporation (IRE) for treating renal (kidney) cancer

Interventional procedures guidance Published February 2013

Chronic kidney disease in adults: assessment and management (CG182)

Evidence-based recommendations on the assessment and management of chronic kidney disease (CKD) in adults

Clinical guideline Published July 2014 Last updated January 2015

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)

Evidence-based recommendations on diagnosing and managing venous thromboembolic diseases (VTE, deep vein thrombosis, DVT, blood clots) in adults

Clinical guideline Published June 2012 Last updated November 2015

Single-port laparoscopic nephrectomy (IPG414)

Evidence-based recommendations on single-port laparoscopic nephrectomy (‘keyhole’ surgery) to remove a kidney

Interventional procedures guidance Published November 2011

Neutropenic sepsis: prevention and management in people with cancer (CG151)

Evidence-based recommendations on preventing and managing neutropenic sepsis in people with cancer who are having anticancer treatment

Clinical guideline Published September 2012

Nivolumab with ipilimumab for untreated metastatic renal cell carcinoma [ID1182]

In development [GID-TA10189] Expected publication date: 03 October 2018

Technology appraisal guidance In development

Laparoscopic partial nephrectomy (IPG151)

Evidence-based recommendations on laparoscopic partial nephrectomy (keyhole surgery to remove kidney tumours)

Interventional procedures guidance Published January 2006

Cabozantinib for untreated locally advanced or metastatic renal cell carcinoma (ID1208)

In development [GID-TA10231] Expected publication date: 03 October 2018

Technology appraisal guidance In development

Type 2 diabetes in adults: management (NG28)

Evidence-based recommendations on the care and management of type 2 diabetes in adults

NICE guideline Published December 2015 Last updated May 2017

Percutaneous radiofrequency ablation for renal cancer (IPG353)

Evidence-based recommendations on percutaneous radiofrequency ablation for treating renal (kidney) cancer

Interventional procedures guidance Published July 2010

Palliative care for adults: strong opioids for pain relief (CG140)

Evidence-based recommendations on strong opioids for pain relief for adults having palliative (end of life) care

Clinical guideline Published May 2012 Last updated August 2016

Pazopanib for the first-line treatment of advanced renal cell carcinoma (TA215)

Evidence-based recommendations on pazopanib (Votrient) for the first-line treatment of advanced renal cell carcinoma (RCC/kidney cancer)

Technology appraisal guidance Published February 2011 Last updated August 2013

Machine perfusion systems and cold static storage of kidneys from deceased donors (TA165)

Evidence-based recommendations on machine perfusion systems and cold static storage of kidneys from deceased donors

Technology appraisal guidance Published January 2009

Lenvatinib with everolimus for previously treated advanced renal cell carcinoma [ID1029]

In development [GID-TA10125] Expected publication date: 24 January 2018

Technology appraisal guidance In development

Tivozanib for treating renal cell carcinoma [ID591]

In development [GID-TA10123] Expected publication date: 28 March 2018

Technology appraisal guidance In development

Non-Hodgkin’s lymphoma: diagnosis and management (NG52)

Evidence-based recommendations on diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years and over

NICE guideline Published July 2016

Immunosuppressive therapy for kidney transplant in adults (TA481)

Evidence-based recommendations on immunosuppressive therapies for preventing kidney rejection in adults

Technology appraisal guidance Published October 2017

Sepsis

Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart

NICE Pathway Published July 2016 Last updated November 2017

Immunosuppressive therapy for kidney transplant in children and young people (TA482)

Evidence-based recommendations on immunosuppressive therapy for kidney transplant in children and young people

Technology appraisal guidance Published October 2017

Irreversible electroporation for treating liver metastases (IPG445)

Evidence-based recommendations on irreversible electroporation (IRE) for treating liver metastases (secondary cancers)

Interventional procedures guidance Published February 2013

Minimally invasive video‑assisted parathyroidectomy (IPG501)

Evidence-based recommendations on minimally invasive (keyhole) video-assisted parathyroidectomy to remove abnormal parathyroid glands

Interventional procedures guidance Published August 2014

Venous thromboembolism

Everything NICE has said on assessing, diagnosing, treating and reducing the risk of venous thromboembolism in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2017

Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment (TA333)

Evidence-based recommendations on axitinib (Inlyta) for treating advanced renal cell carcinoma (RCC) (kidney cancer) when prior systemic treatment has failed

Technology appraisal guidance Published February 2015

Axitinib, everolimus, sorafenib and sunitinib for treated advanced or metastatic renal cell carcinoma [ID897]

In development [GID-TAG526] Expected publication date: TBC

Technology appraisal guidance In development

Eculizumab for treating atypical haemolytic uraemic syndrome (HST1)

70% of patients progress to end‑stage renal failure and need dialysis or die. One patient in 5 has aHUS affecting organs other than the...

Technology appraisal guidance

Atezolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (TA492)

Evidence-based recommendations on atezolizumab (Tecentriq) for treating locally advanced or metastatic urothelial (transitional cell; bladder) cancer in adults

Technology appraisal guidance Published December 2017

Prostate cancer - intensity modulated radiotherapy [ID17]

In development [GID-TAG396] Expected publication date: TBC

Technology appraisal guidance In development

Irreversible electroporation for treating primary lung cancer and metastases in the lung (IPG441)

Evidence-based recommendations on irreversible electroporation (IRE) for treating primary lung cancer and metastases in the lung

Interventional procedures guidance Published February 2013

Irreversible electroporation for treating primary liver cancer (IPG444)

Evidence-based recommendations on irreversible electroporation (IRE) for treating primary liver cancer

Interventional procedures guidance Published February 2013

Sepsis: recognition, diagnosis and early management (NG51)

Evidence-based recommendations on the recognition, diagnosis and early management of sepsis (blood poisoning / septicaemia) in all populations

NICE guideline Published July 2016 Last updated September 2017

News

deal will give people with kidney cancer another treatment option People with

Standards and Indicators

failure in adults Complete Acute kidney injury Complete Acute medical admissions in the first 48 hours Referred Healthcare Acute upper

Published March 2016

Laparoscopic cystectomy (IPG287)

Evidence-based recommendations on laparoscopic cystectomy (keyhole surgery to remove the bladder)

Interventional procedures guidance Published February 2009

Haematological cancers: improving outcomes (NG47)

Evidence-based recommendations on integrated diagnostics reporting and improving services, staffing and care for people with haematological cancer

NICE guideline Published May 2016

Myeloma: diagnosis and management (NG35)

Evidence-based recommendations on the diagnosing and managing of myeloma in people aged 16 and over.

NICE guideline Published February 2016